MSMB gene rs10993994 polymorphism increases the risk of prostate cancer

Tao Peng; Lifeng Zhang; Lijie Zhu; Yuanyuan Mi

doi:10.18632/oncotarget.15312

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

MSMB gene rs10993994 polymorphism increases the risk of prostate cancer

Tao Peng _, Lifeng Zhang, Lijie Zhu and Yuanyuan Mi

PDF | HTML | How to cite

Oncotarget. 2017; 8:28494-28501. https://doi.org/10.18632/oncotarget.15312

Metrics: PDF 1571 views | HTML 1956 views | ?

Abstract

Tao Peng1, Lifeng Zhang2, Lijie Zhu1, Yuan-Yuan Mi1

1Department of Urology, The Third Affiliated Hospital of Nantong University, Wuxi, PR China

2Department of Urology, Changzhou No.2 People′s Hospital Affiliated to Nanjing Medical University, Changzhou, Jiangsu Province, China

Correspondence to:

Lifeng Zhang, email: [email protected]

Lijie Zhu, email: [email protected]

Yuan-Yuan Mi, email: [email protected]

Keywords: MSMB, prostate cancer, rs10993994, meta-analysis, single nucleotide polymorphism

Received: December 01, 2016 Accepted: January 11, 2017 Published: February 14, 2017

ABSTRACT

Genome-wide association studies (GWASs) identified microseminoprotein-β (MSMB) gene rs10993994 polymorphism was significantly associated with prostate cancer (PC) risk. However, the association between MSMB gene rs10993994 polymorphism and PC risk remains controversial. Therefore, we performed a systematic review and meta-analysis by searching in the databases of PubMed, and Embase. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using fixed-effect or random-effect models. A total of 11 publications containing 13 case-control studies for rs10993994 polymorphism were included in our analysis. Our data indicated that MSMB gene rs10993994 polymorphism was associated with an increased risk of PC. Stratification analyses of ethnicity suggested rs10993994 polymorphism increased the risk of PC among Caucasians, but not among Asians. In conclusion, this meta-analysis indicates that MSMB gene rs10993994 polymorphism increases the risk of PC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15312

Publication Alerts

Research Papers:

MSMB gene rs10993994 polymorphism increases the risk of prostate cancer

Abstract